A new generic antiepileptic drug developed by MEDITOP Pharmaceuticals Ltd. has been successfully registered under the DCP in six countries of the European Union (Hungary, Germany, Spain, Portugal, Italy, France).   Read Full Post >>

R&D news

Tuesday, October 18 2022

The September 2022 meeting of the Research Board of the consortium tender 2018-1.3.1-VKE-2018-00030 - 2022 of MEDITOP Pharmaceuticals Ltd. and Semmelweis University summarized the already achieved results.   Read Full Post >>
The 2021 Hungarian Innovation Grand Prize and five other innovation awards were presented on the Europe Boat. A jury of scientists and respected business experts, headed by the Minister of Innovation and Technology, selected the outstanding innovation achievements mainly on the basis of economic indicators - the additional profit, additional revenue achieved - and social utility. In total, world-class achievements with a total social benefit of more than HUF 20 billion were recognised at the Hungarian Innovation Grand Prix award ceremony   Read Full Post >>


Friday, December 3 2021

The Hungarian companies participating in the Healthcare Industry Support Programme (ETP) held their first work-shop meeting in Székesfehérvár on 24.11.2021, which was actively organised by the managing directors of MEDITOP Pharmaceuticals Ltd.   Read Full Post >>

Meditop Pharmaceutical Ltd. was founded in 1991; we were the first of the newly-formed pharmaceutical businesses to obtain a pharmaceutical manufacturing licence after the fall of the communist regime.